Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T12:45:21.759Z.
Calculation as of: 2026-10-06T12:45:21.759Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ad057aee5ab633aed0c7ef60ea3d5b85ea99b1ff07310db4f6411376a188a91d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Market Cap
$837.43M
Operating Cash Flow Yield
N/A
TTM Avg
26.54%
3Y Avg
24.23%
5Y Avg
24.23%
Market Cap
$852.55M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$867.60M
Operating Cash Flow Yield
N/A
TTM Avg
10.89%
3Y Avg
10.89%
5Y Avg
10.89%
Market Cap
$819.44M
Operating Cash Flow Yield
N/A
TTM Avg
0.41%
3Y Avg
2.06%
5Y Avg
3.27%
Market Cap
$786.48M
Operating Cash Flow Yield
N/A
TTM Avg
4.26%
3Y Avg
2.63%
5Y Avg
1.85%
Market Cap
$903.13M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$780.95M
Operating Cash Flow Yield
74.69%
TTM Avg
47.32%
3Y Avg
42.03%
5Y Avg
31.48%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alumis Inc. (ALMS) | $844.28M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $837.43M | N/A | 26.54% | 24.23% | 24.23% |
| Beta Bionics, Inc. (BBNX)vs › | $852.55M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | N/A | 10.89% | 10.89% | 10.89% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | N/A | 0.41% | 2.06% | 3.27% |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | N/A | 4.26% | 2.63% | 1.85% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | N/A | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $780.95M | 74.69% | 47.32% | 42.03% | 31.48% |
| Geron Corporation (GERN)vs › | $776.24M | N/A | 1.73% | 1.73% | 1.73% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
